About a-team Marketing Services
The knowledge platform for the financial technology industry
The knowledge platform for the financial technology industry

A-Team Insight Blogs

Thomson Reuters Returns to the EMS Market Through Acquisition of REDI Holdings

Subscribe to our newsletter

Thomson Reuters is returning to the execution management system (EMS) space through a definitive agreement to acquire REDI Holdings and its flagship EMS that provides broker-neutral, cross-asset trade execution capabilities for the buy-side trading community.

Here at ITT, we flagged the imminent acquisition of REDI by Thomson Reuters back in June and, sure enough, the deal is now in the making, taking Thomson Reuters into a sector where it has been active in the past but with mixed results, and enabling it to offer its clients an alternative to Bloomberg’s widely used EMSX. Financial details of the acquisition have not been disclosed, but it is expected to close by the end of this year.

Thomson Reuters says that by integrating REDI’s trading capabilities into its Eikon desktop and Elektron data and trading propositions, it will be able to provide an integrated platform on which institutional traders can move from pre-trade activities to trade execution.

Michael Chin, managing director, global head of equities, Thomson Reuters, explains: “Integrating REDI into Thomson Reuters solutions will enable us to transform Eikon into a world-class trading solution for the buy-side and further expand the breadth and depth of market data available to them via Elektron. Like Thomson Reuters, REDI has a long commitment to innovation through its open technology platform that integrates third-party data, applications and capabilities, a core tenet of Thomson Reuters own strategy.”

Founded in 1992 by market maker and New York Stock Exchange specialist Spear, Leeds & Kellogg, REDI has a good track record of delivering EMS capabilities to the buy-side. From 2001 to 2013, REDI was owned and operated by Goldman Sachs. In 2013, Goldman Sachs spun out the REDI business into a collaborative, industry-backed consortium including Bank of America Merrill Lynch, Barclays, BNP Paribas, Citadel and investment funds affiliated with Lightyear Capital and Goldman Sachs. Bank of America Merrill Lynch also transferred its InstaQuote EMS to REDI as part of its investment.

Subscribe to our newsletter

Related content

WEBINAR

Upcoming Webinar: Navigating the Build vs Buy Dilemma: Cloud Strategies for Accelerating Quantitative Research

Date: 20 May 2026 Time: 10:00am ET / 3:00pm London / 4:00pm CET Duration: 50 minutes For many quantitative trading firms and asset managers, building a self-provisioned historical market data environment remains one of the most time-consuming and resource-intensive steps in establishing a new research capability. Sourcing data, normalising symbologies, handling corporate actions and maintaining...

BLOG

Axiory.ai Launches AI Agent Trading Platform Built on Model Context Protocol

Axiory.ai, a platform developed by the global brokerage Axiory in partnership with Purple Technology, has launched an infrastructure layer designed to allow AI agents to access and trade across multi-asset CFD markets through a single standardised environment. The platform is built on Anthropic’s Model Context Protocol (MCP), the open standard for connecting AI systems to...

EVENT

Data Management Summit London

Now in its 16th year, the Data Management Summit (DMS) in London brings together the European capital markets enterprise data management community, to explore how data strategy is evolving to drive business outcomes and speed to market in changing times.

GUIDE

FRTB Special Report

FRTB is one of the most sweeping and transformative pieces of regulation to hit the financial markets in the last two decades. With the deadline confirmed as January 2022, this Special Report provides a detailed insight into exactly what the data requirements are for FRTB in its latest (and final) incarnation, and explores what needs to be done in order to meet these needs on a cost-effective and company-wide basis.